Complement regulationMERI, S; JARVA, H.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 291-302, issn 0042-9007, SUP2Conference Paper

Complement and biocompatibilityMOLLNES, T. E.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 303-307, issn 0042-9007, SUP2Conference Paper

Emerging viruses in blood transfusionALLAIN, J.-P.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 125-129, issn 0042-9007, SUP2Conference Paper

Mass media and health servicesKARHU, M.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 111-113, issn 0042-9007, SUP2Conference Paper

Organizational changes in EstoniaEVERAUS, H.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 531-533, issn 0042-9007, SUP2Conference Paper

Transmission of parasites by blood transfusionDODD, R. Y.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 161-163, issn 0042-9007, SUP2Conference Paper

Replacement of massive blood lossHIIPPALA, S.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 399-407, issn 0042-9007, SUP2Conference Paper

Requirements for the electronic crossmatchJUDD, W. J.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 409-417, issn 0042-9007, SUP2Conference Paper

The French hæmovigilance systemNOEL, L; DEBEIR, J; COSSON, A et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 441-445, issn 0042-9007, SUP2Conference Paper

Antigens on red cellsANSTEE, D. J.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 255-257, issn 0042-9007, SUP2Conference Paper

Epidemiology of the hepatitis C virusEBELING, F.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 143-146, issn 0042-9007, SUP2Conference Paper

Stem cell biology for the transfusionistLANSDORP, P. M.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 91-94, issn 0042-9007, SUP2Conference Paper

Factors determining quality of plasmaMYLLYLÄ, G.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 507-511, issn 0042-9007, SUP2Conference Paper

Microbiological safety of blood transfusionBARBARA, J. A. J.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 11-13, issn 0042-9007, SUP2Conference Paper

GMP in blood collection and processingWAGSTAFF, W.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 513-521, issn 0042-9007, SUP2Conference Paper

Virus inactivation of fresh plasmaMOHR, H.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 171-172, issn 0042-9007, SUP2Conference Paper

Evaluation of serological platelet antibody assaysKAPLAN, C.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 355-358, issn 0042-9007, SUP2Conference Paper

Alternatives to human blood and blood resourcesPROWSE, C. V.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 21-28, issn 0042-9007, SUP2Conference Paper

EBV specific CTL : A model for immune therapyROONEY, C. M; HESLOP, H. E; BRENNER, M. K et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 497-498, issn 0042-9007, SUP2Conference Paper

Ex vivo expansion of cord blood progenitorsPIACIBELLO, W; SANAVIO, F; SEVERINO, A et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 457-462, issn 0042-9007, SUP2Conference Paper

Experiences with self service electronic blood bankingCHENG, G.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 427-429, issn 0042-9007, SUP2Conference Paper

Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentratesCORASH, L.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 173-176, issn 0042-9007, SUP2Conference Paper

Screening programmes for foetomaternal alloimmune thrombocytopeniaWILLIAMSON, L. M.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 385-389, issn 0042-9007, SUP2Conference Paper

From Karl Landsteiner to human xenotransplantationSAMUEISSON, B.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 65-68, issn 0042-9007, SUP2Conference Paper

Donor selection : The exclusion of high risk donors?VAN DEN BURG, P. J. M; VRIELINK, H; REESINK, H. W et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 499-502, issn 0042-9007, SUP2Conference Paper